PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases.

Autor: Gallucci, Gina M.¹ (AUTHOR), Hayes, Colleen M.¹ (AUTHOR), Boyer, James L.² (AUTHOR), Barbier, Olivier³ (AUTHOR), Assis, David N.² (AUTHOR), Ghonem, Nisanne S.¹ (AUTHOR) nghonem@uri.edu

Publikováno v: Cells (2073-4409). Aug2024, Vol. 13 Issue 15, p1296. 12p.

PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.

Autor: Hayes CM; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA., Gallucci GM; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA., Boyer JL; Section of Digestive Diseases and Yale Liver Center, Yale School of Medicine, New Haven, Connecticut, USA., Assis DN; Section of Digestive Diseases and Yale Liver Center, Yale School of Medicine, New Haven, Connecticut, USA., Ghonem NS; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.

Publikováno v: Hepatology communications [Hepatol Commun] 2024 Dec 20; Vol. 9 (1). Date of Electronic Publication: 2024 Dec 20 (Print Publication: 2025).